CryoLife Reviewing Tissue Sterilization Process In Wake Of Warning Letter
This article was originally published in The Gray Sheet
Executive Summary
FDA is increasing its scrutiny over validation of tissue processing practices, as evidenced by a June 17 warning letter to CryoLife